Preterm Eylem
Referanslar
Taşkın, L. Doğum ve Kadın Sağlığı Hemşireliği. (6. Baskı). Ankara: Akademisyen Yayınevi; 2019.
WHO. The WHO Reproductive Health Library 2015. (17/11/2023 tarihinde https://www.who.int/publications/i/item/9789240028012 adresinden ulaşılmıştır).
Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008; 371(9606):75-84. doi: 10.1016/S0140-6736(08)60074-4.
Chirikov M, Schlabritz-Loutsevitch N, Maher J et al. Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome. Journal of Perinatal Medicine. 2018; 46(5):465-488. doi: 10.1515/jpm-2017-0027.
Kelly R, Holzman C, Senagore P, et al. Placental vascular pathology findings and pathways to preterm delivery. American Journal of Epidemiolohy. 2009;170(2):148-158. doi: 10.1093/aje/kwp131.jpg.
Lobel M, Dunkel-Schetter C, Scrimshaw SC. Prenatal maternal stress and prematurity: a prospec- tive study of socioeconomically disadvantaged women. Health Psychology. 1992;11(1):32-40. doi: 10.1037//0278-6133.11.1.32.
FIGO. Good clinical practice advice: Antenatal corticosteroids for fetal lung maturation. Intertanational Journal of Gynecology & Obstetrics, 2019;144(3):352-355. doi: 10.1002/ijgo.12746.
Cobo T, Kacerovsky M, Jacobsson B. Risk factors for spontaneous preterm delivery. International Journal of Gynecology & Obstetrics. 2020;150(1):17-23. doi: 10.1002/ijgo.13184.
Wei SQ, Fraser W, Luo ZC. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstetrics & Gynecology. 2010;116(2): 393-401. doi: 10.1097/AOG.0b013e3181e6dbc0.
Lockwood CJ. Risk factors for preterm birth and new approaches to its earlydiagnosis. Journal of Perinatal Medicine. 2015;43(5):499-501. doi: 10.1515/jpm-2015-0261.
Vidaeff AC, Monga M, Ramin SM, et al. Is thrombin activation predictive of subsequent pretermdelivery? American Journal of Obstetrics & Gynecology. 2013;208(4):306 e1-7. doi: 10.1016/j.ajog.2013.01.037.
Roberts D, Brown J, Medley N, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews. 2017;(3)3:CD004454. doi: 10.1002/14651858.CD004454.pub3.
Suhag A. Preterm birth prevention in asymptomatic women. Berghella V (Ed.), Obstetric Evidence Based Guidelines, New York: CRC Press; 2017.193-212.
Norman JE, Bennett P. Preterm birth prevention-Time to progress beyond progesterone. PLOS Medicine. 2017;14(9):e1002391. https://doi.org/10.1371/journal.pmed.1002391.
Manuck TA, Esplin MS, Biggio J, et al. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth. American Journal of Obstetrics & Gynecology. 2016;214:376. https://doi.org/10.1016/j.ajog.2015.12.010.
ACOG. ACOG Committee Opinion No 764: Tıbbi Endikasyonlu Geç Pretyerm ve Erken Term Doğumlar 2022. (15/11/2023 tarihinde https://www.acog.org. adresinden ulaşılmıştır).
SMFM. Society for Maternal-Fetal Medicine Statement: Response to the Food and Drug Administration's withdrawal of 17-alpha hydroxyprogesterone caproate. American Journal of Obstetrics & Gynecology. 2023; 229(1):2-6. doi: 10.1016/j.ajog.2023.04.012.
Senat MV, Porcher R, Winer N, et al. Prevention of preterm delivery by 17 alpha-hydroxyproges- terone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial. American Journal of Obstetrics & Gynecology. 2013;208(3):194.e1-8. doi: 10.1016/j.ajog.2013.01.032.
Carbonne, B. Is it possible to improve diagnostic and prognostic criteria of preterm labour? European Journal of Obstetrics & Gynecology and Reproductive Biology. 2004;117(1):6-9. doi: 10.1016/j.ejogrb.2004.07.008.
Dayan J, Creveuil C, Herlicoviez M, et al. Role of anxiety and depression in the onset of spontaneous preterm labor. American Journal of Epidemiology. 2002;155(4):293-301. doi: 10.1093/aje/155.4.293.
Emery SP, Bahtiyar MO, Nashe JS, et al. The north American fetal therapy network consensus statement: Prenatal management of uncomplicated monochorionic gestations. Obstetrics and Gynecology. 2015;125(5):1236-1243. doi: 10.1097/AOG.00000000000000723.
ACOG. ACOG Committee Opinion No: 713. Antenatal corticosteroid therapy for fetal maturation 2017. (16/11/2023 tarihinde https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/08/antenatal-corticosteroid-therapy-for-fetal-maturation adresinden ulaşılmıştır).
Dagklis T, Şen C, Tsakiridis I, et al. The use of antenatal corticosteroids for fetal maturation: clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine foundation. Jourbal of Perinatal Medicine. 2022;50(4):375-385. doi: 10.1515/jpm-2022-0066.
Raikkönen K, Gissler M, Kajantie E. Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children. Journal of The American Medical Association. 2020;323(19):1924-1933. doi: 10.1001/jama.2020.3937.
Vogel JP, Ramson J, Darmstadt GL, et al. Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes. Lancet Global Health. 2022;10(12):1707-1708. doi:10.1016/S2214-109X(22)00434-X.
NICE. Preterm labour and birth 2017. (10/11/2023 tarihinde https://www.nice.org.uk/ adresinden ulaşılmıştır).
Skoll A, Boutin A, Bujold E, et al. No. 364-Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes. Journal of Obstetrics and Gynaecology Canada. 2018;40(9):1219-1239. doi: 10.1016/j.jogc.2018.04.018.
Berger R, Abele H, Bahlmann F, et al. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes. Geburtshilfe Frauenheilkd. 2019;79(8):813- 833. doi: 10.1055/a-0903-2735.
Rundell K, Panchal B. Preterm Labor: Prevention and Management. American Family Physician. 2017;95(6):366-72.